Marc Cartellieri is currently the Chief Technology Officer at AvenCell, a position held since 2021. Previously, they served as Chief Scientific Officer at Cellex Patient Treatment GmbH from 2014 to 2021 and held post-doctoral fellow roles at the Institute of Radiopharmaceutical Cancer Research and the Department of Immunology at University Hospital Dresden from 2005 to 2014, focusing on immunotherapy innovations. Marc earned a PhD from the Department of Virology at University Hospital Dresden in 2005 and completed a diploma in Zoology at Ernst-Moritz-Arndt-Universität Greifswald in 2000.
This person is not in any teams
This person is not in any offices